Leadership Team
Jack Hoppin, Ph.D.
Chairman, Chief Executive Officer
Konica Minolta Precision Medicine (President), Invicro (Co-Founder), Emit Imaging (Co-Founder, Chairman)
John Babich, Ph.D.
Director, President, Chief Scientific Officer
Weill Cornell Medicine, Molecular Insight Pharmaceuticals (Co-Founder), MGH/HMS, RMH/ICR, NASA, BNL
Marc Becker, M.B.A, CPA
Chief Financial and Operating Officer
KPMG, BankBoston (now Bank of America), Genzyme, rEVO Biologics, CRISPR Therapeutics, Concert Pharmaceuticals, Flagship Pioneering
William Cupelo, M.B.A, M.S.
Chief Business Officer
Invicro
Stephen DiMagno, Ph.D.
Chief Techonology Officer
UIC Pharmaceutical Sciences (Head), Ikaria (Co-founder), Osteoanalgesia, University of Nebraska, Ground Fluor Pharmaceuticals (Co-Founder), University of Pennsylvania, UC Berkeley
Matthias Friebe, Ph.D.
Chief Development Officer
Piramal Imaging, Bayer AG, Schering AG, Harvard Medical School, Swiss Federal Institute of Technology
Colin Hayward, M.B. B.S.
Chief Medical Officer
Roche Pharmaceuticals, Myriad Genetics, Premier Research, Telix Pharmaceuticals
Jacob Hesterman, Ph.D.
Chief Data Officer
Realm IDx, Invicro, Beth Israel Deaconess Medical Center, Bioscan, Inc
Marcel Reichen, Ph.D, M.B.A
Chief Strategy Officer
Bayer AG, Novartis AG
Scott Holbrook
Manufacturing Advisor
Pharmalogic, Adjunct Assistant Professor University of Utah, Co-Founder Invivo Molecular Imaging and Precision Nuclear
Alejandro Amor Coarasa, Ph.D.
Head of Radiochemistry
Albert Einstein College of Medicine, Weill Cornell Medicine, Florida International University
Shawn Hillier, Ph.D.
Executive Vice President and Head of Preclinical Development
Symbiotix Biotherapies, Moderna Therapeutics, Vertex Pharmaceuticals, Molecular Insight Pharmaceuticals, MIT
Victoria Jardine, Ph.D.
Vice President, Global Clinical Development
Bayer, ARTBIO, Cambridge University, Addenbrooke’s Hospital
John Marquis, Ph.D.
Vice President of Biology
Merck & Co., Molecular Insight Pharmaceuticals, MIT, Harvard
Scott MacDonald, J.D., M.B.A
Vice President, Head of Legal
Voyager Therapeutics, Foundation Medicine
Kelly Orcutt, Ph.D.
Head of Quantitative Sciences
Viewpoint Molecular Targeting, Invicro, University of Iowa, Harvard Medical School, MIT
Christine Redmond
Vice President, Clinical Operations and Program Management
Bill and Melinda Gates Medical Research Institute, Biogen, Synta Pharmaceuticals, Lantheus Medical Imaging, Molecular Insight, Dyax, Acorda Therapeutics
Elizabeth Romero, M.S.
General Manager, Ratio Utah and Head of Global Clinical Trial Supply
PharmaLogic, ARRT Board of Trustees, Columbia University (New York State Psychiatric Institute), Memorial Sloan Kettering Cancer Center
William “Mo” Cowan, J.D.
Director
Former United States Senator, President, Global Government Affairs & Policy, General Electric Co., Chief Legal & External Affairs Officer, Devoted Health, Inc., Duke University, Northeastern University School of Law
Allan Green, M.D., Ph.D., J.D.
Director & Regulatory Consultant
Ground Fluor Pharmaceuticals, Atreus Pharmaceuticals, Theseus Imaging, NASI, NEN, Boston College Law School
Al Holman
Director
Founder and Co-Managing Partner, Chestnut Partners, Inc. Trustee and Chair of Finance Committee, Mass General Brigham
Susan K. Whoriskey, Ph.D.
Director
Founding Executive Team of Vera Therapeutics, Moderna, Momenta Pharmaceuticals, Cubist Pharmaceuticals